12 Biggest Mid-Day Losers For Monday

shares tumbled 31.6 percent to $33.64.

dropped 17.4 percent to $7.69. CSI Compressco lowered its quarterly cash distribution to $0.1875 per outstanding common unit. CSI Compressco is expected to release its Q1 earnings results on Tuesday, May 9, 2017.

shares declined 10.4 percent to $1.38.

shares fell 9.9 percent to $2.18. Johnson & Weaver, LLP announced investigations of Ocwen and Hain Celestial.

shares dropped 9.3 percent to $7.01 after the company reported results from its Phase 2 proof-of-concept study of prolactin inhibition.

shares declined 8 percent to $18.86. Akari Therapeutics disclosed that it demonstrated positive response with Coversin in its Phase 2 PNH trial.

fell 5.7 percent to $28.80 after gaining 9.31 percent on Friday.

shares declined 5 percent to $3.80 after rising 6.67 percent on Friday.

shares fell 5 percent to $3.65 after dropping 2.04 percent on Friday.

dropped 4.4 percent to $177.15 after the company announced plans to acquire C R Bard for $24 billion.

declined 4.2 percent to $34.21. Barclays downgraded Mazor Robotics from Overweight to Equal-Weight.

declined 4 percent to $23.28. Jefferies initiated coverage on Jernigan Capital with a Hold rating.